Soleno Therapeutics, Inc. (SLNO) Q3 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Soleno Therapeutics, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:02.474 Good afternoon and thank you for standing by. 00:00:02.474 -- 00:00:07.639 Welcome to Celeno Therapeutics' third quarter, 2025 Financial and 00:00:07.639 -- 00:00:11.123 Operating Results Conference Call and Webcast. 00:00:11.123 -- 00:00:14.587 Currently, all participants are in a listen-only mode. 00:00:14.587 -- 00:00:19.152 After the speaker's presentation, there will be a question and answer session. 00:00:19.152 -- 00:00:22.475 As a reminder, today's webcast is being recorded. 00:00:22.475 -- 00:00:24.057 I 00:00:24.057 -- 00:00:27.521 would now like to introduce Brian Ritchie of Lifesite Advisors. 00:00:27.521 -- 00:00:30.062 Please go ahead. 00:00:30.693 -- 00:00:31.734 Thank you. 00:00:31.734 -- 00:00:37.380 Good afternoon, everyone, and thank you for joining us to discuss Celeno Therapeutics' 00:00:37.380 -- 00:00:40.483 third quarter 2025 financial 00:00:40.483 -- 00:00:45.929 and operating results. Please note, we will be making certain forward-looking statements 00:00:45.929 -- 00:00:51.214 today. We refer you to Celeno's SEC filings for a discussion of the risks 00:00:51.214 -- 00:00:56.620 that may cause actual results to differ from the forward-looking statements. 00:00:56.620 -- 00:01:01.597 On the call with me today for Celeno are Anish Bhatnagar, Solano's Chairman and Chief 00:01:01.597 -- 00:01:06.664 Executive Officer, Meredith Manning, Solano's Chief Commercial Officer, 00:01:06.664 -- 00:01:10.149 and Jim McInnis, Solano's Chief Financial Officer. 00:01:10.149 -- 00:01:14.333 With that, I will now turn the call over to Anish. 00:01:14.816 -- 00:01:19.443 Thank you, Brian, and thank you, everyone, for joining us for our third quarter results 00:01:19.443 -- 00:01:21.526 call this afternoon. 00:01:21.526 -- 00:...